DIAGNOSIS AND MANAGEMENT OF HEREDITARY ANGIOEDEMA (HAE)ATKINSON JP.1979; ANN. ALLERGY; USA; DA. 1979; VOL. 42; NO 6; PP. 348-352; BIBL. 21 REF.Article

ENTFERNUNG VON SCHWEFELWASSERSTOFF AUS GASEN = REMOVAL OF HYDROGEN SULPHIDE FROM GASES = ELIMINATION DE L'HYDROGENE SULFURE DE GAZATKINSON JP.1976; ERDOEL KOHLE ERDGAS PETROCHEM.; DTSCH.; DA. 1976; VOL. 29; NO 5; PP. 203-205; ABS. ANGL.Article

METHODE EPROUVEE D'ELIMINATION DE L'HYDROGENE SULFUREATKINSON JP.1976; KOKS SMOLA GAZ; POLSKA; DA. 1976; VOL. 21; NO 4; PP. 133-135Article

CYTOCHALASIN BINDING TO MACROPHAGESATKINSON JP; PARKER CW.1978; CELL. IMMUNOL.; USA; DA. 1978; VOL. 41; NO 1; PP. 103-121; BIBL. 42 REF.Article

MODULATION OF MACROPHAGE FC RECEPTOR FUNCTION BY CYTOCHALASIN-SENSITIVE STRUCTURES.ATKINSON JP; PARKER CW.1977; CELL. IMMUNOL.; U.S.A.; DA. 1977; VOL. 33; NO 2; PP. 353-363; BIBL. 41 REF.Article

ROLE OF COMPLEMENT IN THE PATHOPHYSIOLOGY OF HEMATOLOGIC DISEASES.ATKINSON JP; FRANK MM.1977; PROGR. IN HEMATOL.; U.S.A.; DA. 1977; VOL. 10; PP. 211-245; BIBL. 6 P. 1/2Article

THE EFFECT OF BACILLUS CALMETTE-GUERIN-INDUCED MACROPHAGE ACTIVATION ON THE IN VIVO CLEARANCE OF SENSITIZED ERYTHROCYTESATKINSON JP; FRANK MM.1974; J. CLIN. INVEST.; U.S.A.; DA. 1974; VOL. 53; NO 6; PP. 1743-1749; BIBL. 1P.Article

DEVELOPMENT AND CHARACTERIZATION OF A HEMOLYTIC ASSAY FOR MOUSE C4ATKINSON JP; MCGINNIS K; SHREFFLER D et al.1980; J. IMMUNOL. METHODS; NLD; DA. 1980; VOL. 33; NO 4; PP. 351-368; BIBL. 28 REF.Article

MOLECULAR CHARACTERIZATION OF THE SS AND SLP (C4) PROTEINS OF THE MOUSE H-2 COMPLEX: SUBUNIT COMPOSITION, CHAIN SIZE POLYMORPHISM, AND AN INTRACELLULAR CPRO-SS) PRECURSORROOS MH; ATKINSON JP; SHREFFLER DC et al.1978; J. IMMUNOL.; USA; DA. 1978; VOL. 121; NO 3; PP. 1106-1115; BIBL. 29 REF.Article

HEREDITARY ANGIOEDEMA: THE CLINICAL SYNDROME AND ITS MANAGEMENTFRANK MM; GELFAND JA; ATKINSON JP et al.1976; ANN. INTERN. MED.; U.S.A.; DA. 1976; VOL. 84; NO 5; PP. 580-593; BIBL. 1 P. 1/2Article

HUMORAL IMMUNOSTIMULATION. VI. INCREASED CALCIUM UPTAKE BY CELLS TREATED WITH ANTIBODY AND COMPLEMENT.SHEARER WT; ATKINSON JP; PARKER CW et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 117; NO 3; PP. 973-980; BIBL. 1 P. 1/2Article

METABOLIC BEHAVIOR OF C3 IN NORMAL, C4-DEFICIENT (C4D) AND CORTISONE-TREATED GUINEA PIGSATKINSON JP; HYUN SHIN; FRANK MM et al.1974; J. IMMUNOL.; U.S.A.; DA. 1974; VOL. 113; NO 4; PP. 1085-1092; BIBL. 28REF.Article

GENETIC VARIATION IN GLYCOSYLATION OF THE FOURTH COMPONENT OF MURINE COMPLEMENT: ASSOCIATION WITH HEMOLYTIC ACTIVITYKARP DR; ATKINSON JP; SHREFFLER DC et al.1982; JOURNAL OF BIOLOGICAL CHEMISTRY; ISSN 0021-9258; USA; DA. 1982; VOL. 257; NO 13; PP. 7330-7335; BIBL. 36 REF.Article

STIMULATION OF THE RESPIRATORY BURST IN HUMAN NEUTROPHILS BY CRYSTAL PHAGOCYTOSISSIMCHOWITZ L; ATKINSON JP; SPILBERG I et al.1982; ARTHRITIS RHEUM.; ISSN 0004-3591; USA; DA. 1982; VOL. 25; NO 2; PP. 181-188; BIBL. 19 REF.Article

PLATELET RELEASE REACTION AND INTRACELLULAR CGMPWEISS A; BAENZIGER NL; ATKINSON JP et al.1978; BLOOD; USA; DA. 1978; VOL. 52; NO 3; PP. 524-531; BIBL. 21 REF.Article

COLD AGGLUTININS AND COLD-AGGLUTININ DISEASE.FRANK MM; ATKINSON JP; GADEK J et al.1977; ANNU. REV. MED.; U.S.A.; DA. 1977; VOL. 28; PP. 291-298; BIBL. 2 P.Article

STIMULUS-SPECIFIC DEACTIVATION OF CHEMOTACTIC FACTOR-INDUCED CYCLIC AMP RESPONSE AND SUPEROXIDE GENERATION BY HUMAN NEUTROPHILSSIMCHOWITZ L; ATKINSON JP; SPILBERG I et al.1980; J. CLIN. INVEST.; ISSN 0021-9738; USA; DA. 1980; VOL. 66; NO 4; PP. 736-747; BIBL. 32 REF.Article

CHARACTERIZATION OF THE M_R DIFFERENCE BETWEEN SECRETED MURINE FOURTH COMPONENT OF COMPLEMENT AND THE MAJOR PLASMA FORM: EVIDENCE FOR CARBOXYL-TERMINAL CLEAVAGE OF THE ALPHA CHAINKARP DR; SHREFFLER DC; ATKINSON JP et al.1982; PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. BIOLOGICAL SCIENCES; ISSN 0273-1134; USA; DA. 1982; VOL. 79; NO 21; PP. 6666-6670; BIBL. 39 REF.Article

THE ROLE OF COMPLEMENT IN THE CLEARANCE OF COLD AGGLUTININS-SENSITIZED ERYTHROCYTES IN MAN.JAFFE CJ; ATKINSON JP; FRANK MM et al.1976; J. CLIN. INVEST.; U.S.A.; DA. 1976; VOL. 58; NO 4; PP. 942-949; BIBL. 29 REF.Article

HEMOLYTIC AND ANTIGENIC MEASUREMENTS OF COMPLEMENT: A COMPARISON OF SERUM AND PLASMA SAMPLES IN NORMAL INDIVIDUALS AND PATIENTSNEWELL S; GORMAN JC; BELL E et al.1982; J. LAB. CLIN. MED.; ISSN 0022-2143; USA; DA. 1982; VOL. 100; NO 3; PP. 437-444; BIBL. 19 REF.Article

ISOLATION OF A BIOLOGICALLY ACTIVE MACROPHAGE RECEPTOR FOR THE THIRD COMPONENT OF COMPLEMENTSCHNEIDER RJ; KULCZYCKI A JR; LAW SK et al.1981; NATURE (LOND.); ISSN 0028-0836; GBR; DA. 1981; VOL. 290; NO 5809; PP. 789-792; BIBL. 21 REF.Article

CYCLIC AMP CONCENTRATIONS IN HUMAN PERIPHERAL BLOOD LYMPHOCYTES: CHANGES IN ASSOCIATION WITH CELL PURIFICATIONGOFFSTEIN BJ; GORDON LK; WEDNER HJ et al.1980; J. LAB. CLIN. MED.; ISSN 0022-2143; USA; DA. 1980; VOL. 96; NO 6; PP. 1002-1014; BIBL. 31 REF.Article

DEVELOPMENT OF A HEMOLYTIC ASSAY FOR MOUSE C2 AND DETERMINATION OF ITS GENETIC CONTROLGORMAN JC; JACKSON R; DESANTOLA JR et al.1980; J. IMMUNOL.; USA; DA. 1980; VOL. 125; NO 1; PP. 344-351; BIBL. 31 REF.Article

PURIFICATION OF FCGAMMA RECEPTOR FORM RABBIT ALVEOLAR MACROPHAGES THAT RETAINS LIGAND-BINDING ACTIVITYKULCZYCKRI A JR; KRAUSE V; CHEW KILLION C et al.1980; J. IMMUNOL.; USA; DA. 1980; VOL. 124; NO 6; PP. 2772-2779; BIBL. 54 REF.Article

REDUCED CONCENTRATIONS OF THE FIRST COMPONENT OF COMPLEMENT IN HYPOGAMMAGLOBULINEMIA: CORRECTION BY INFUSION OF GAMMA -GLOBULIN.ATKINSON JP; FISHER RI; REINHARDT R et al.1978; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1978; VOL. 9; NO 3; PP. 350-355; BIBL. 28 REF.Article